Literature DB >> 20490897

Hearts of surviving MLP-KO mice show transient changes of intracellular calcium handling.

Péter Kemecsei1, Zsuzsanna Miklós, Tamás Bíró, Rita Marincsák, Balázs I Tóth, Edina Komlódi-Pásztor, Eniko Barnucz, Eva Mirk, Ger J Van der Vusse, László Ligeti, Tamás Ivanics.   

Abstract

The muscle Lim protein knock-out (MLP-KO) mouse model is extensively used for studying the pathophysiology of dilated cardiomyopathy. However, explanation is lacking for the observed long survival of the diseased mice which develop until adulthood despite the gene defect, which theoretically predestines them to early death due to heart failure. We hypothesized that adaptive changes of cardiac intracellular calcium (Ca(i)(2+)) handling might explain the phenomenon. In order to study the progression of changes in cardiac function and Ca(i)(2+) cycling, myocardial Ca(i)(2+)-transients recorded by Indo-1 surface fluorometry were assessed with concomitant measurement of hemodynamic performance in isolated Langendorff-perfused hearts of 3- and 9-month old MLP-KO animals. Hearts were challenged with beta-agonist isoproterenol and the sarcoplasmic reticular Ca(2+)-ATPase (SERCA2a) inhibitor cyclopiazonic acid (CPA). Cardiac mRNA content and levels of key Ca(2+) handling proteins were also measured. A decline in lusitropic function was observed in 3-month old, but not in 9-month old MLP-KO mice under unchallenged conditions. beta-adrenergic responses to isoproterenol were similar in all the studied groups. The CPA induced an increase in end-diastolic Ca(i)(2+)-level and a decrease in Ca(2+)-sequestration capacity in 3-month old MLP-KO mice compared to age-matched controls. This unfavorable condition was absent at 9 months of age. SERCA2a expression was lower in 3-month old MLP-KO than in the corresponding controls and in 9-month old MLP-KO hearts. Our results show time-related recovery of hemodynamic function and an age-dependent compensatory upregulation of Ca(i)(2+) handling in hearts of MLP-KO mice, which most likely involve the normalization of the expression of SERCA2a in the affected hearts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490897     DOI: 10.1007/s11010-010-0492-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.

Authors:  S Arber; J J Hunter; J Ross; M Hongo; G Sansig; J Borg; J C Perriard; K R Chien; P Caroni
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs.

Authors:  L Fülöp; T Bányász; G Szabó; I B Tóth; T Bíró; I Lôrincz; A Balogh; K Petô; I Mikó; P P Nánási
Journal:  Acta Physiol (Oxf)       Date:  2006 Nov-Dec       Impact factor: 6.311

3.  Calibration of indo-1 and resting intracellular [Ca]i in intact rabbit cardiac myocytes.

Authors:  J W Bassani; R A Bassani; D M Bers
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

4.  Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure.

Authors:  Gudrun Antoons; Peter Vangheluwe; Paul G A Volders; Virginie Bito; Patricia Holemans; Marcello Ceci; Frank Wuytack; Pico Caroni; Kanigula Mubagwa; Karin R Sipido
Journal:  J Mol Cell Cardiol       Date:  2006-01-20       Impact factor: 5.000

5.  Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.

Authors:  J Martijn Bos; Rainer N Poley; Melissa Ny; David J Tester; Xiaolei Xu; Matteo Vatta; Jeffrey A Towbin; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Mol Genet Metab       Date:  2005-12-13       Impact factor: 4.797

6.  Cellular and functional defects in a mouse model of heart failure.

Authors:  G Esposito; L F Santana; K Dilly; J D Cruz; L Mao; W J Lederer; H A Rockman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

7.  Role of diastolic properties in the transition to failure in a mouse model of the cardiac dilatation.

Authors:  Peter N Costandi; Lawrence R Frank; Andrew D McCulloch; Jeffrey H Omens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-21       Impact factor: 4.733

8.  Mathematical modelling of the calcium-left ventricular pressure relationship in the intact diabetic rat heart.

Authors:  J Op Den Buijs; L Ligeti; T Ivanics; Z Miklós; G J Van Der Vusse; N A W Van Riel
Journal:  Acta Physiol (Oxf)       Date:  2008-02-18       Impact factor: 6.311

9.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.

Authors:  H A Rockman; K R Chien; D J Choi; G Iaccarino; J J Hunter; J Ross; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

View more
  4 in total

Review 1.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

2.  Opposing Roles of S1P3 Receptors in Myocardial Function.

Authors:  Dina Wafa; Nóra Koch; Janka Kovács; Margit Kerék; Richard L Proia; Gábor J Tigyi; Zoltán Benyó; Zsuzsanna Miklós
Journal:  Cells       Date:  2020-07-24       Impact factor: 6.600

Review 3.  When signalling goes wrong: pathogenic variants in structural and signalling proteins causing cardiomyopathies.

Authors:  Mehroz Ehsan; He Jiang; Kate L Thomson; Katja Gehmlich
Journal:  J Muscle Res Cell Motil       Date:  2017-11-08       Impact factor: 2.698

4.  Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation.

Authors:  Zsuzsanna Miklós; Dina Wafa; György L Nádasy; Zsuzsanna E Tóth; Balázs Besztercei; Gabriella Dörnyei; Zsófia Laska; Zoltán Benyó; Tamás Ivanics; László Hunyady; Mária Szekeres
Journal:  Cells       Date:  2021-03-24       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.